- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
340 CHAPTER 7 Miscellaneous urological diseases of kidney
Autosomal dominant (adult) polycystic kidney disease (ADPKD)
Definition
ADPKD is an autosomal dominant inherited disorder leading to the development of multiple expanding renal parenchymal cysts.
Epidemiology
Incidence is 0.1%; 95% of cases are bilateral. Symptoms manifest in the fourth decade. ADPKD accounts for 10% of all cases of renal failure.
Pathology
The kidneys reach an enormous size due to multiple fluid-filled cysts and can easily be palpated on abdominal examination. Expansion of the cysts results in ischemic atrophy of the surrounding renal parenchyma and obstruction of normal renal tubules.
End-stage renal failure is inevitable and occurs around the age of 50 years.
Associated disorders
These include a 10–30% incidence of Circle of Willis berry aneurysms (associated with subarachnoid hemorrhage); cysts of the liver (33%), pancreas (10%), and spleen (<5%); renal adenoma; cardiac valve abnormalities; aortic aneurysms; and diverticular disease.
Etiology
PKD-1 gene defects (chromosome 16) account for 90% of cases; PKD-2 gene defects (chromosome 4) cause 10%, and now a third gene, PKD-3 is also implicated.
Pathogenesis theories include intrinsic basement membrane abnormalities; tubular epithelial hyperplasia (causing tubular obstruction and basement membrane weakness); and alterations in the supportive extracellular matrix due to defective proteins, all of which may cause cyst formation.
Presentation
Patients have a positive family history (50% inheritance); palpable abdominal masses; flank pain (due to mass effect, infection, stones, or following acute cystic distension due to hemorrhage or obstruction); macroscopic (and microscopic) hematuria; UTI; and hypertension (75%).
Renal failure may present with lethargy, nausea, vomiting, anemia, confusion, and seizures.
Differential diagnosis
This includes renal tumors; simple cysts; von Hippel–Landau syndrome (cerebellar and retinal hemangioblastomas; renal, adrenal, and pancreatic cysts); and tuberous sclerosis (adenoma sebaceum, epilepsy, learning difficulties, with polycystic kidneys and renal tumors).
AUTOSOMAL DOMINANT (ADULT) POLYCYSTIC KIDNEY DISEASE 341
Investigation
This depends on the presenting symptoms.
-For suspected UTI—culture urine
-For hematuria—urine cytology, flexible cystoscopy, and renal ultrasound. On ultrasound the kidneys are small and hyperechoic, with multiple cysts of varying size, many of which show calcification. If the nature of the cysts cannot be determined with certainty on ultrasound, arrange for a renal CT.
-Renal failure will be managed by a nephrologist. Anemia may occur, though ADPKD may cause increased erythropoietin production and polycythemia.
-Renal imaging (ultrasound and CT are useful for investigation of complications)
Treatment
The aim is to preserve renal function as long as possible (control hypertension and UTI). Infected cysts (abscesses) should be drained.
Persistent, heavy hematuria can be controlled by embolization or nephrectomy.
Progressive renal failure requires dialysis and, ultimately, renal transplantation.
342 CHAPTER 7 Miscellaneous urological diseases of kidney
Vesicoureteric reflux (VUR) in adults
VUR is the retrograde flow of urine from the bladder into the upper urinary tract with or without dilatation of the ureter, renal pelvis, and calyces. It can cause symptoms and may lead to renal failure (reflux nephropathy). In adults 10–15% of patients requiring hemodialysis or transplantation do so because of reflux nephropathy.
Pathophysiology
Reflux is normally prevented by low bladder pressures, efficient ureteric peristalsis, and the ability of the vesicoureteric junction (VUJ) to occlude the distal ureter during bladder contraction. This is assisted by the ureter passing obliquely through the bladder wall (the “intramural” ureter), which is 1–2 cm long. Normal intramural ureteric length to ureteric diameter ratio is 5:1.
VUR of childhood tends to resolve spontaneously with increasing age because as the bladder grows, the intramural ureter lengthens.
Classification
Primary
A primary anatomical (and therefore functional) defect is where the intramural length of the ureter is too short (ratio <5:1).
Secondary
A secondary defect is secondary to some other anatomical or functional problem:
-Bladder outlet obstruction (BPO, DSD due to neuropathic disorders,1 posterior urethral valves, urethral stricture) that leads to elevated bladder pressures
-Poor bladder compliance or the intermittently elevated pressures of detrusor hyperreflexia (due to neuropathic disorders1—e.g., spinal cord injury, spina bifida)
-Iatrogenic reflux following TURP or TURBT (a tumor overlying the ureteric orifice)—this is rare; ureteric meatotomy (incision of the ureteric orifice) for removal of ureteric stones at the VUJ; following incision of a ureterocele; ureteroneocystostomy; after pelvic radiotherapy
-Inflammatory conditions affecting function of the VUJ: TB, schistosomiasis, UTI
Associated disorders
VUR is commonly seen in duplex ureters (the Meyer–Weigert law).2 Cystitis can cause VUR through bladder inflammation, reduced bladder compliance, increased pressures, and distortion of the VUJ. Coexistence of UTI with VUR is a potent cause of pyelonephritis—reflux of infected urine under high pressure causes reflux nephropathy, resulting in renal scarring, hypertension, and renal impairment.
1 Neuropathic disorders therefore cause VUR because they lead to intermittently or chronically raised bladder pressure (due to BOO, poor compliance, and/or detrusor hyperreflexia).
2 The lower pole ureter inserts into the bladder in a proximal location to the upper pole ureter, which inserts distally—i.e., nearer the bladder neck. The lower pole ureter has a shorter intramural length and therefore refluxes. The upper pole ureter has a longer intramural length and tends to be obstructed.
VESICOURETERIC REFLUX (VUR) IN ADULTS 343
Presentation
-VUR may be symptomless, being identified during VCUG, IVP, or renal ultrasound (which shows ureteric and renal pelvis dilatation) done for some other cause.
-UTI symptoms
-Flank pain associated with a full bladder or immediately after micturition
Symptoms of recurrent UTI or of flank pain may have been present for many years before the patient seeks medical advice. Even then it may take some time for a diagnosis of VUR to be made because a high index of suspicion is required and the definitive test for making a diagnosis of VUR (VCUG—see below) is invasive (although VUR may be diagnosed by the less invasive use of IVP).
Investigation
The definitive test for the diagnosis of VUR is cystography. VUR may be apparent during bladder filling or during voiding (voiding cystourethrography [VCUG]—also known as micturating cystourethrography [MCUG]).
Urodynamics establishes the presence of voiding dysfunction (e.g., DSD) if this is suspected from the clinical picture. If there is radiographic evidence of reflux nephropathy, check blood pressure, check the urine for proteinuria, measure serum creatinine, and arrange for a 99mTc-DMSA isotope study to assess renal cortical scarring and determine split renal function.
Management
VUR is harmful to the kidney:
-In the presence of infected urine
-Where bladder pressures are markedly elevated (due to severe BOO, poor compliance, or high-pressure hyperreflexic bladder contractions)
In the absence of urinary infection or severe outflow obstruction/ raised bladder pressures, VUR is not harmful, at least in the short term (months).
Subsequent management depends on the following:
-The presence and severity of symptoms
-The presence of recurrent, bacteriologically proven urinary infection
-The presence of already established renal damage (radiological evidence of reflux nephropathy, hypertension, proteinuria— proteinuria is a poor prognostic factor in patients with VUR, indicating the likelihood of impending end-stage renal failure)
For the patient with primary VUR, recurrent UTIs with no symptoms between infections, no hypertension, and good renal function, treat the UTIs when they occur and consider low-dose antibiotic prophylaxis if UTIs occur frequently (say >3 per year). If the UTIs are regularly associated with constitutional disturbance (acute pyelonephritis rather than simple cystitis), then ureteric reimplantation is indicated.
344 CHAPTER 7 Miscellaneous urological diseases of kidney
For the patient with primary VUR and objective evidence of deterioration in the affected kidney (i.e., progressive radiological signs of reflux nephropathy or reduction in renal function), use ureteric reimplantation.
Reflux into a nonfunctioning kidney (<10% function on DMSA scan) with recurrent UTIs and/or hypertension requires nephroureterectomy.
Primary reflux with severe recurrent flank pain requires ureteric reimplantation.
Secondary reflux
For secondary reflux into a transplanted kidney, no treatment is needed. For VUR in association with the neuropathic bladder, treat the underlying cause—relieve BOO and improve bladder compliance (options: intravesical Botox injections, augmentation cystoplasty, sacral
deafferentation).
For VUR with no symptoms, no UTI, no high bladder pressures and no BOO, the management of these patients is controversial because it is not known whether low-pressure, sterile reflux causes deterioration in renal function over many years without treatment.
Grade I and II reflux (reflux of contrast into nondilated ureter) probably does not require surgery, and many urologists would not recommend surgery but would monitor the patient for infection, hypertension, and evidence of deterioration in the appearance and function of the kidneys.
Grade III or more may require surgical intervention, and many urologists would recommend ureteric reimplantation or a STING procedure (see Fig. 7.1 for grading system for reflux).
VESICOURETERIC REFLUX (VUR) IN ADULTS 345
Grade I |
II |
III |
IV |
V |
Grade I Contrast into non-dilated ureter
Grade II Contrast into renal pelvis and calyces; no dilatation Grade III Mild dilatation of ureter; pelvis, and calyces
Grade IV Dilated ureter becomes slightly tortuous; moderate dilatation of pelvis and blunting of calyces
Grade V Severe ureteric dilatation and tortuosity; gross dilatation of pelvis and calyces
Figure 7.1 International reflux classification